Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

Coppo, R.; Troyanov, S.; Bellur, S.; Cattran, D.; Cook, H.T.; Feehally, J.; ... ; VALIGA Study ERA-EDTA (2014)

Article / Letter to editor

• glomerular diseases
• IgA nephropathy
• progression of chronic renal failure
• proteinuria
• renal pathology
• risk factors

• All authors: Coppo, R.; Troyanov, S.; Bellur, S.; Cattran, D.; Cook, H.T.; Feehally, J.; Roberts, I.S.D.; Morando, L.; Camilla, R.; Tesar, V.; Lunberg, S.; Gesualdo, L.; Emma, F.; Rollino, C.; Amore, A.; Praga, M.; Feriozzi, S.; Segoloni, G.; Pani, A.; Cancarini, G.; Durlik, M.; Moggia, E.; Mazzucco, G.; Giannakakis, C.; Honsova, E.; Sundelin, B.B.; Palma, A.M. di; Ferrario, F.; Gutierrez, E.; Asunis, A.M.; Barratt, J.; Tardanico, R.; Perkowska-Ptasinska, A.; VALIGA Study ERA-EDTA
• Date: 2014-10-31
• Journal: Kidney International
• Volume: 86
• Issue: 4
• Pages: 828 - 836
• DOI: doi:10.1038/ki.2014.63